What is next?I am not sure of what to make of the management of this company. On the positive side they seem to be getting a little maturity -- ie, they no longer stop trading over every little announcement. When they were stop trading each time, they seemed like a bunch of clowns to me. They finally have an actual trial taking place where they will have to publish the results. If, like they are touting, the drug does help the recovery and lessen lung damage, this should be an ideal company for a takeover. Even, if the stock goes 3 or 4X, it would still be a cheap acquisition. If the results are inconclusive, then where do we end up - 20 cents?